Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
Launches collaborative centre for translational research in head and neck cancer
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Darunavir is a protease inhibitor antiviral medicine that prevents Human Immunodeficiency Virus (HIV-1) from multiplying in the body
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
Almost 300 million people globally have chronic hepatitis B
Subscribe To Our Newsletter & Stay Updated
